Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and tolerability of nebicapone in Parkinson's disease patients with wearing-off on levodopa/DDCI
2006-001793-24Phase 2Completed
- Sponsor
- BIAL
- Start
- Jul 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of nebicapone in Parkinson's disease (PD) (3 arms), sponsored by BIAL. Primary endpoint: Change from baseline in absolute off-time. Started Jul 2006; status: completed.
02
Drugs
nebicapone
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on 2006-001793-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001793-24.